Highly active antiretroviral therapy (Haart) for the treatment of infection with human immunodeficiency virus type 1-Reference-Cited by-同舟云学术

Highly active antiretroviral therapy (Haart) for the treatment of infection with human immunodeficiency virus type 1

Published:1999-03 Issue:2 Volume:53 Page:73-86
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Shafer R.W.,Vuitton D.A

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference105 articles.

1. Report of the NIH Panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents;Centers for Disease Control Prevention;MMWR,1998

2. Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel;Carpenter;JAMA,1998

3. 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing Committee;Gazzard;Lancet,1998

4. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma;Sun;J Clin Microbiol,1998

5. Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen;Nolermans;AIDS,1998

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infiltrative and sclerotic right chest wall plaque;JAAD Case Reports;2024-09

2. Deciphering the enigmas of non‐nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistance;Medicinal Research Reviews;2024-08-26

3. A systematic review assessing the association of inflammatory markers with kidney dysfunction in people living with HIV on highly active antiretroviral therapy;BMC Infectious Diseases;2024-08-02

4. Infectious optic neuropathy (ION), how to recognise it and manage it;Eye;2024-06-03

5. In situ sustained release hydrogel system delivering GLUT1 inhibitor and chemo-drug for cancer post-surgical treatment;Bioactive Materials;2024-06